SHCSotera Health Company

1. Aug 14, 2026On August 11, 2026, James C. Neary notified the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) of his resignation as a Class I director, effective August 13, 2026 (the “Effective Date”)Director or officer change · Form 8-K
2. Aug 6, 2026Sotera Health Delivers Strong Second-Quarter and.Earnings release · press release
3. May 20, 2026Credit Agreement On May 20, 2026, Sotera Health Company (the “Company”), Sotera Health Holdings, LLC (“SHH”), certain subsidiaries of the Company, each 2026 Refinancing Term Lender (the “Refinancing Lenders”) and JPMorgan Chase Bank, N.A., as first lien Administrative Agent (the “Administrative Agent”) entered into …Material agreement entered · Form 8-K
4. May 13, 2026On May 13, 2026, the stockholders’ agreement (the “Stockholders Agreement”) by and among Sotera Health Company (the “Company”) and the stockholders party thereto, dated as of November 19, 2020, terminated pursuant to its terms as described below under.Material agreement terminated · Form 8-K
5. May 5, 2026In accordance with the Company’s executive succession plans, on May 5, 2026, the Company announced a leadership transition pursuant to which, on May 1, 2026, the Board of Directors (the “Board”), at the recommendation of the Nominating and Corporate Governance Committee, appointed Alton Shader to serve as Chief …Earnings release · Form 8-K
6. Mar 16, 2026On March 12, 2026, as a result of a reduction in the number of directors that certain stockholders are entitled to designate for election to the Board of Directors (the “Board”) of Sotera Health Company (the “Company”), Constantine S. Mihas notified the Board of his intention to resign as a Class I director, effective …Director or officer change · Form 8-K
7. Mar 6, 2026On March 4, 2026, Sotera Health Company (the “Company”), certain stockholders named in Schedule 2 thereto (the “Selling Stockholders”) and Wells Fargo Securities, LLC, as underwriter (the “Underwriter”), entered into an underwriting agreement (the “Underwriting Agreement”) relating to the sale of 25,000,000 shares …Other event · Form 8-K
8. Feb 24, 2026On February 18, 2026, Alex Dimitrief, Senior Vice President and General Counsel of the Company, provided notice to the Company that he will retire on March 31, 2026.Earnings release · Form 8-K
9. Feb 5, 2026On February 4, 2026, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Richard G. Kyle as a Class III director of the Board, effective immediately.Director or officer change · Form 8-K
10. Jan 12, 2026Sotera Health to Showcase Continued Revenue.Earnings release · press release
11. Nov 10, 2025On November 6, 2025, Sotera Health Company, certain stockholders named in Schedule 2 thereto (the “Selling Stockholders”) and Goldman Sachs & Co. LLC, as underwriter (the “Underwriter”), entered into an underwriting agreement (the “Underwriting Agreement”) relating to the sale of 30,000,000 shares (the “Shares”) of …Other event · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.